Mda mb 468 breast cancer cell line
The MDA-MB-468 breast cancer cell line is a well-established model for breast cancer research. It is a triple-negative breast cancer cell line, meaning it lacks the expression of estrogen receptor, progesterone receptor, and HER2. This cell line is commonly used to study the biology and behavior of this particular subtype of breast cancer.
Lab products found in correlation
3 protocols using mda mb 468 breast cancer cell line
Culturing MDA-MB-468 Breast Cancer Cells
Establishment and Culture of Burkitt Lymphoma Cell Lines
PHGDH inhibitor NCT-503 (N-(4,6-dimethylpyridin-2-yl)-4-(4-(trifluoromethyl)benzyl) piperazine-1-carbothioamide) and NCT-503 inactive control (N-(4,6-dimethylpyridin-2-yl)-4-(pyridin-4-yl)piperazine-1-carbothioamide), unable to inhibit PHGDH) were purchased from Sigma-Aldrich. Glutaminase inhibitor CB-839 was purchased from MedChemExpress. All compounds were diluted in sterile dimethyl sulfoxide (DMSO) to obtain 10 mM stocks, aliquoted, and stored in 2–8 °C according to manufacturer’s recommendations.
Antibody-mediated cytotoxicity assay
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!